Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25641323 | 0.79 | — | — | |
| SCHEMBL2991947 | 0.76 | CA1 (0.39) | CA1CA2CA4 | |
| SCHEMBL22551053 | 0.75 | — | — | |
| SCHEMBL19260517 | 0.75 | — | — | |
| SCHEMBL19260516 | 0.75 | — | — | |
| SCHEMBL10708118 | 0.74 | — | — | |
| SCHEMBL1397962 | 0.74 | — | — | |
| SCHEMBL19250386 | 0.72 | CA1 (0.34) | CA1CA2CA4 | |
| SCHEMBL23223204 | 0.71 | CA1 (0.44) | CA1CA2CA4 | |
| SCHEMBL14123415 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091418-B2 | Organoleptic compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2021-08-17 | — | — | US | disclosed |
| US-20200331834-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331834-A1 | NOVEL ORGANOLEPTIC COMPOUNDS | TRPA1, TRPV1, TRPV5 | CA1 1907/4885CA2 2848/4885CA4 549/4885 |
| US-11091418-B2 | Organoleptic compounds | TRPA1, TRPV1, TRPV5 | CA1 1409/4885CA2 2389/4885CA4 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.